Targeted therapy of multiple myeloma
Multiple myeloma (MM) is a malignant proliferative disease of monoclonal plasma cells (PCs) and is characterized by uncontrolled proliferation of PCs and excessive production of specific types of immunoglobulins. Since PCs are terminally differentiated B cells, the World Health Organization (WHO) cl...
Guardado en:
Autores principales: | Shan Zhou, Renxi Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Open Exploration Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/52c45691c8d9471199f1baa11f339240 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multiple myeloma
por: Larisa P. Mendeleeva, et al.
Publicado: (2021) -
IMMUNE DISTURBANCES IN PATIENTS WITH MULTIPLE MYELOMA
por: E. A. Senkina, et al.
Publicado: (2014) -
Development and validation of an expanded targeted sequencing panel for non-invasive prenatal diagnosis of sporadic skeletal dysplasia
por: Ching-Yuan Wang, et al.
Publicado: (2021) -
Incidence, etiology, and course of hypercalcemia-induced AKI in a tertiary care center from northern India
por: Nucksheeba Aziz Bhat, et al.
Publicado: (2021) -
CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma
por: Kim De Veirman, et al.
Publicado: (2021)